{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T03:45:03Z","timestamp":1648611903871},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[1985,1,1]],"date-time":"1985-01-01T00:00:00Z","timestamp":473385600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[1985,1]]},"DOI":"10.1007\/bf01644230","type":"journal-article","created":{"date-parts":[[2005,5,7]],"date-time":"2005-05-07T07:33:08Z","timestamp":1115451188000},"page":"S112-S114","source":"Crossref","is-referenced-by-count":2,"title":["Clinical experience of cefotaxime in infections caused by gram-positive pathogens"],"prefix":"10.1007","volume":"13","author":[{"given":"D.","family":"Bassetti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Solbiati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Fraizzoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"1530","volume-title":"Principles and practice of infectious diseases","author":"I. M. Smith","year":"1979","unstructured":"Smith, I. M., Bentley, D. W., Bisno, A. L. Staphylococci and streptococci. In:Mandell, G. L., Douglas, R. G., Jr., Bennet, J. (eds.): Principles and practice of infectious diseases. J. Wiley & Sons, New York 1979, pp. 1530\u20131561."},{"key":"CR2","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/jac\/4.5.437","volume":"4","author":"J. M. T. Hamilton-Miller","year":"1978","unstructured":"Hamilton-Miller, J. M. T., Brumfitt, W., Reynolds, A. V. Cefotaxime (HR 756), a new cephalosporin with exceptional broadspectrum activityin vitro. J. Antimicrob. Chemother. Suppl. 4 (1978) 437\u2013444.","journal-title":"J. Antimicrob. Chemother. Suppl."},{"key":"CR3","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1128\/AAC.17.5.856","volume":"17","author":"E. Yourassowky","year":"1980","unstructured":"Yourassowky, E., van der Linden, M. P., Lismont, M. J., Crokcert, F. Activity of ten cephalosporins on biomass of methicillin-susceptible and resistantStaphylococcus aureus. Antimicrob. Agents Chemother. Suppl. 17 (1980) 856\u2013860.","journal-title":"Antimicrob. Agents Chemother. Suppl."},{"key":"CR4","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1128\/AAC.16.6.757","volume":"17","author":"R. P. Mouton","year":"1979","unstructured":"Mouton, R. P., Bongaerts, G. P. A., van Gestel, M. Comparison of activity and beta-lactamase stability of cefotaxime with those of six other cephalosporins. Antimicrob. Agents Chemother. Suppl. 17 (1979) 757\u2013760.","journal-title":"Antimicrob. Agents Chemother. Suppl."},{"key":"CR5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000237902","volume":"26","author":"G. Peters","year":"1980","unstructured":"Peters, G., Pulverer, G. Comparativein vitro activity of cefotaxime (HR 756). Chemotherapy 26 (1980) 177\u2013183.","journal-title":"Chemotherapy"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"376","DOI":"10.7326\/0003-4819-97-3-376","volume":"97","author":"C. Watanakunakorn","year":"1982","unstructured":"Watanakunakorn, C. Treatment of infections due to methicillin-resistantStaphylococcus aureus. Ann. Intern. Med. Suppl. 97 (1982) 376\u2013379.","journal-title":"Ann. Intern. Med. Suppl."},{"key":"CR7","first-page":"177","volume":"41","author":"C. O. Solberg","year":"1983","unstructured":"Solberg, C. O., Digranes, A., Kalager, T. Therapy of staphylococcal septicaemia in compromised hosts. Scand. J. Infect. Dis. Suppl. 41 (1983) 177\u2013184.","journal-title":"Scand. J. Infect. Dis. Suppl."},{"key":"CR8","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/clinids\/4.Supplement_2.S411","volume":"4","author":"B. R. Meyers","year":"1982","unstructured":"Meyers, B. R. Clinical experience with cefotaxime in the treatment of patients with bacteremia. Rev. Infec. Dis. Suppl. 4 (1982) 411\u2013415.","journal-title":"Rev. Infec. Dis. Suppl."},{"key":"CR9","unstructured":"Bint, A. J., Hamilton, P. J., Charlton, J., Hiller, C.: Cefotaxime plus gentamicin therapy for febrile neutropenic patients. 20th Interscience Conference Antimicrob. Agents Chemother. Seattle 1980, Abstract no. 21."},{"key":"CR10","unstructured":"Neu, H. C.: Comparative activity of new cephalosporins against beta-lactamase-producing bacteria: In:Nelson, J. D., Grassi, C. (eds.): Current chemotherapy and infectious diseases. Vol. 1. Washington D. C. 1980, p. 23."},{"key":"CR11","unstructured":"Gaya, H., Sacks, T., Good, A., Upton, C., Glicksman, C.: Synergy between some newer aminoglycosides and beta-lactam antibiotics. In:Nelson, J. D., Grassi, C. (eds.): Current chemotherapy and infectious diseases. Vol. I. Washington D. C. 1980, p. 485."},{"key":"CR12","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1128\/AAC.22.5.903","volume":"22","author":"C. Watanakunakorn","year":"1982","unstructured":"Watanakunakorn, C., Tisone, J. C. Synergism between vancomycin and gentamicin or tobramycin for methicillin-susceptible and methicillin-resistantStaphylococcus aureus. Antimicrob. Agents Chemother. Suppl. 22 (1982) 903\u2013909.","journal-title":"Antimicrob. Agents Chemother. Suppl."},{"key":"CR13","unstructured":"Bartholomew, L. R., Minns, G. O., Voth, D. W.: Survivorship ofStreptococcus faecalis that exhibit the \u201cEagle Effect\u201d. 24th Interscience Conference Antimicrob. Agents Chemother. Washington 1984, Abstract no. 1117."},{"key":"CR14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/jac\/6.suppl_A.263","volume":"14","author":"M. Armengaud","year":"1980","unstructured":"Armengaud, M., Massip, P., Aubertin, J., Raynaud, J. M. Cefotaxime in the treatment of septicaemia and endocarditis. J. Antimicrob. Chemother. Suppl. 14 (1980) 263\u2013268.","journal-title":"J. Antimicrob. Chemother. Suppl."},{"key":"CR15","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1128\/AAC.21.1.119","volume":"21","author":"P. H. Karakusis","year":"1982","unstructured":"Karakusis, P. H., Feczko, J. M., Goodman, L. J., Hanson, D. M., Harris, A. A., Levin, S., Tenholme, G. M. Clinical efficacy of cefotaxime in serious infections. Antimicrob. Agents Chemother. Suppl. 21 (1982) 119\u2013124.","journal-title":"Antimicrob. Agents Chemother. Suppl."}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01644230.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01644230\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01644230","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T12:30:39Z","timestamp":1557232239000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01644230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,1]]},"references-count":15,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[1985,1]]}},"alternative-id":["BF01644230"],"URL":"https:\/\/doi.org\/10.1007\/bf01644230","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,1]]}}}